Infective endocarditis caused by multidrug-resistant Streptococcus mitis in a combined immunocompromised patient: An autopsy case report

Journal of Infection and Chemotherapy

Volumn 19, Issue 2, 2013, Pages 321-325

  Matsui, Natsuko ^a   Ito, Makoto ^a   Kuramae, Hitoshi ^a   Inukai, Tomomi ^a   Sakai, Akiyoshi ^a   Okugawa, Masaru ^a  

^a Toyota Kai Medical Corporation Kariya Toyota General Hospital   (Japan)

Author keywords

Compromised host; Infective endocarditis; Multidrug resistance; Streptococcus mitis

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; MACROLIDE; MINOCYCLINE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOPSY; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; CAUSAL ATTRIBUTION; CLINICAL FEATURE; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE STATUS; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN A DEFICIENCY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; RECURRENT INFECTION; SPLENECTOMY; STEROID THERAPY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS; TONSIL DISEASE;

EID: 84880699877     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0465-9     Document Type: Article

References (17)

1. Prabhu RM, Piper KE, Baddour LM, Steckelberg JM, Wilson WR, Patel R. Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother. 2004;48:4463-5.
2. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rate of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother. 1996;40:891-4.
3. Poutanen SM, de Azavedo J, Willey BM, Low DE, MacDonald KS. Molecular characterization of multidrug resistance in Streptococcus mitis. Antimicrob Agents Chemother. 1999;43:1505-7.
4. de Azavedo JCS, Trpeski L, Pong-Porter S, Matsumura S, The Canadian Bacterial Surveillance Network, Low DE. In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada. Antimicrob Agents Chemother. 1999;43:2299-301.
5. Cerdá Zolezzi P, Laplana LM, Calvo CR, Cepero PG, Erazo MC, Gómez-Lus R. Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae. Antimicrob Agents Chemother. 2004;48:3462-7.
6. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002;34:1524-9.
7. Knoll B, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis. 2007;44:1585-92.
8. Seppälä H, Haanperä M, Al-Juhaish M, Järvinen H, Jalava J, Huovinen P. Antimicrobial susceptibility patterns and macrolide resistance genes of viridians group streptococci from normal flora. J Antimicrob Chemother. 2003;52:636-44.
9. Ergin A, Eser ÖK, Hasçelik G. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases. New Microbiol. 2011;34:187-93.
10. Achour W, Guenni O, Malbruny B, Canu A, Leclercq R, Hassen AB. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients. J Antimicrob Chemother. 2004;54:117-21.
11. Teng LJ, Hsueh PR, Chen YC, Ho SW, Luh KT. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother. 1998;41:621-7.
12. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, 7th ed. Approved standard M7-A6. Wayne: Clinical and Laboratory Standards Institute; 2006.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 17th ed. Approved standard M100-S17. Wayne: Clinical and Laboratory Standards Institute; 2007.
14. Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K, et al. Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001. Circ J. 2003;67:901-5.
15. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol. 2001;54:214-8.
16. Okabayashi T, Hanazaki K. Overwhelming postsplenectomy infection syndrome in adults: a clinically preventable disease. World J Gastroenterol. 2008;14:176-9.
17. Usui H, Takao A, Nakayama A, Nagashima H, Sasaki F, Maeda N, Ishibashi K. Detection of penicillin-binding protein 2b gene alteration in Streptococcus mitis by polymerase chain reaction. J Infect Chemother. 2004;10:19-24.